Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

  • There is currently no data for POLX

Director dealing

2 Jan 2020 16:50

RNS Number : 6117Y
Polarean Imaging PLC
02 January 2020
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

Director Dealing

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 31 December 2019 that Mr Richard Hullihen, the Company's CEO, has purchased a total of 347,100 ordinary shares of £0.00037 ("Ordinary Shares") via three transactions which are summarised in the table below (the "Transactions").

Date of Transaction

Number of Ordinary Shares purchased

Price per Ordinary Share

13 December 2019

100,000

20.22p

16 December 2019

100,000

20.02p

27 December 2019

147,100

23.87p

 

Following this Transactions, Mr Hullihen holds a beneficial interest in 2,928,899 Ordinary Shares, representing 2.56 per cent. of the Company's issued share capital with voting rights.

 

Enquiries: 

 

Polarean Imaging plc 

www.polarean.com / www.polarean-ir.com 

Richard Hullihen, Chief Executive Officer 

Via Walbrook PR 

Richard Morgan, Chairman 

 

 

 

SP Angel Corporate Finance LLP 

Tel: +44 (0)20 3470 0470  

David Hignell / Soltan Tagiev (Corporate Finance) 

 

Vadim Alexandre / Rob Rees (Corporate Broking)

 

 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Mr Richard Hullihen

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Polarean Imaging Plc

b)

LEI:

213800DGR2BHXJ36OL37

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Ordinary shares of £0.00037

GB00BF3DT583

b)

Nature of the transaction:

Purchase of shares

c)

Price(s) and volume(s):

 

Transaction

Price(s)

Volume(s)

(i)

(ii)

(iii)

20.22 pence

20.02 pence

23.87 pence

100,000

100,000

147,100

 

d)

Aggregated information:

Aggregated volume:

Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

See above

347,100

 

 

 

e)

Date of the transactions:

(i): 13 December 2019

(ii): 16 December 2019

(iii): 27 December 2019

f)

Place of the transactions:

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZGGMVZNGGZM
Date   Source Headline
23rd Dec 20257:00 amRNSCancellation - Polarean Imaging Plc
15th Dec 20254:03 pmRNSResult of General Meeting
1st Dec 20257:00 amRNSChest coil passes Philips compatibility testing
25th Nov 20257:00 amRNSFirst Xenon Hyperpolariser in Asia
24th Nov 20257:00 amRNSKorean distributor agreement with DK Healthcare
14th Nov 20257:00 amRNSProposed Cancellation of Admission & Notice of GM
27th Oct 20253:37 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSStrategic review and consideration of AIM listing
6th Oct 20257:00 amRNSAscend Imaging agreement expansion
29th Sep 20257:00 amRNSUniversity of Virginia Health Hospital agreement
25th Sep 202512:14 pmRNSNational Institutes of Health system order
25th Sep 20257:00 amRNSHalf-year Report
16th Sep 20257:00 amRNSNotice of Results
11th Sep 20254:36 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSSubmission of new Phase III study protocol to FDA
24th Jul 20257:00 amRNSBlock Listing Six Monthly Return
24th Jun 20257:00 amRNSPromotion & sales representative agreement
9th Jun 20254:16 pmRNSResult of AGM
2nd Jun 20257:00 amRNSFDA expands XENOVIEW indication
21st May 20257:00 amRNSDr. Bastiaan Driehuys awarded by ATS
15th May 202512:48 pmRNSXenon MRI featured prominently at ATS 2025
14th May 20252:25 pmRNSOngoing collaboration with Philips
8th May 20257:00 amRNSFinal Results
6th May 20252:59 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSNotice of Results
10th Mar 20257:00 amRNSExpansion of Xenon MRI imaging platform
27th Feb 20257:00 amRNSFY24 trading update
19th Feb 20257:00 amRNSVirtual Investor Day
3rd Feb 20257:00 amRNSTaiwanese distributor agreement with Sumtage
30th Jan 20257:00 amRNSKey patent in China secured
28th Jan 20257:00 amRNSCollaboration to Advance Lung Imaging Innovation
24th Jan 20257:00 amRNSBlock Listing Six Monthly Return
11th Dec 20242:52 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFDA clears Chest Coil in GE HealthCare MRI Systems
25th Sep 20247:00 amRNSVirtual investor day
4th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20247:00 amRNSAppointment of Vice President of Sales
28th Aug 20247:00 amRNSAppointment of Chief Medical Advisor
21st Aug 20247:00 amRNSNotice of Results
15th Aug 20247:00 amRNSAppointment of Bastiaan Driehuys as consultant
1st Aug 20247:00 amRNSFDA submission to expand minimum age for XENOVIEW™
31st Jul 20247:00 amRNSNew Xenon MRI System trade-in agreement
29th Jul 20247:00 amRNSRepricing of Options and Grant of Options
26th Jul 20247:00 amRNSBlock Listing Six Monthly Return
24th Jul 20242:36 pmRNSResult of AGM
19th Jul 202410:36 amRNSXenon MRI System trade-in agreement
18th Jul 20245:33 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSFinal Results
19th Jun 20245:23 pmRNSHolding(s) in Company
19th Jun 20245:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.